D
Market Data
$6.48−$1.30 (−16.71%)
DMAC · Last trade
Prev Close
$7.78
Range (30d)
$6.42 – $7.95
Recent Filings
- 8-K375.0 KBDiaMedica Therapeutics Inc.Mar 30, 6:40 PM ET·0001437749-26-010409
- 10-K10.9 MBDiaMedica Therapeutics Inc.Mar 30, 5:34 PM ET·0001437749-26-010342
- 8-K149.4 KBDiaMedica Therapeutics Inc.Jan 5, 9:15 AM ET·0001437749-26-000175
- 8-K189.0 KBDiaMedica Therapeutics Inc.Dec 18, 8:45 AM ET·0001437749-25-038211
- 10-Q5.5 MBDiaMedica Therapeutics Inc.Nov 12, 11:33 AM ET·0001437749-25-034469
- 8-K399.8 KBDiaMedica Therapeutics Inc.Nov 12, 11:31 AM ET·0001437749-25-034467
- 8-K174.1 KBDiaMedica Therapeutics Inc.Aug 12, 5:27 PM ET·0001437749-25-026286
- 10-Q5.3 MBDiaMedica Therapeutics Inc.Aug 12, 4:17 PM ET·0001437749-25-026207
- 8-K407.2 KBDiaMedica Therapeutics Inc.Aug 12, 4:15 PM ET·0001437749-25-026205
- 8-K255.3 KBDiaMedica Therapeutics Inc.Aug 6, 8:00 AM ET·0001437749-25-024956
Insiders
10- ALCORN HARRY W JRChief Medical Officer
- Burroughs Amy L.Director
- Cundari Dominic RChief Commercial Officer
- Daves Julie VanOrsdelSVP Clinical Development Oper.
- Gilman Sydney A.VP, Regulatory Affairs
- Giuffre Randall MichaelDirector
- Gruis Kirsten LChief Medical Officer
- JACINTO RICHARD II10% Owner
- Kellen ScottCFO & Secretary
- Krop JulieChief Marketing Officer
Tickers
Addresses
business
301 CARLSON PARKWAY SUITE 210
MINNEAPOLIS, MN, 55305
mailing
301 CARLSON PARKWAY SUITE 210
MINNEAPOLIS, MN, 55305
Former Names
- DiaMedica Inc.2014-03-11